Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients

R. V. Iaffaioli, G. Frasci, L. Rinaldi, L. Del Vecchio, A. Tortoriello, G. Facchini, V. Perone, V. Montesarchio, C. Vacca, F. Vaia, A. R. Bianco

Research output: Contribution to journalArticle

Abstract

The immunologic status of 40 breast cancer patients with operable disease and 50 healthy women was studied at the Division of Medical Oncology of the 2nd Medical School in Naples. Skin tests and lymphocyte subpopulation determination were performed. The same tests were repeated after surgery in the cancer patients. At the same time, the immunologic modifications during chemotherapy (CMF) were studied in a further 25 premenopausal breast cancer patients. The cancer patients did not show significantly different reactivity to recall antigens, nor did surgery or chemotherapy modify this parameter. The breast cancer patients showed a significantly higher CD4+/CD8+ ratio (2.07±1.06 vs. 1.56±0.58; p

Original languageEnglish
Pages (from-to)412-418
Number of pages7
JournalEuropean Journal of Gynaecological Oncology
Volume14
Issue number5
Publication statusPublished - 1993

Fingerprint

Breast Neoplasms
Drug Therapy
CD4-CD8 Ratio
Medical Oncology
Lymphocyte Subsets
Skin Tests
Medical Schools
Neoplasms
Antigens

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients. / Iaffaioli, R. V.; Frasci, G.; Rinaldi, L.; Del Vecchio, L.; Tortoriello, A.; Facchini, G.; Perone, V.; Montesarchio, V.; Vacca, C.; Vaia, F.; Bianco, A. R.

In: European Journal of Gynaecological Oncology, Vol. 14, No. 5, 1993, p. 412-418.

Research output: Contribution to journalArticle

Iaffaioli, RV, Frasci, G, Rinaldi, L, Del Vecchio, L, Tortoriello, A, Facchini, G, Perone, V, Montesarchio, V, Vacca, C, Vaia, F & Bianco, AR 1993, 'Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients', European Journal of Gynaecological Oncology, vol. 14, no. 5, pp. 412-418.
Iaffaioli, R. V. ; Frasci, G. ; Rinaldi, L. ; Del Vecchio, L. ; Tortoriello, A. ; Facchini, G. ; Perone, V. ; Montesarchio, V. ; Vacca, C. ; Vaia, F. ; Bianco, A. R. / Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients. In: European Journal of Gynaecological Oncology. 1993 ; Vol. 14, No. 5. pp. 412-418.
@article{1640a6b03b24435ea6686872af246ad3,
title = "Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients",
abstract = "The immunologic status of 40 breast cancer patients with operable disease and 50 healthy women was studied at the Division of Medical Oncology of the 2nd Medical School in Naples. Skin tests and lymphocyte subpopulation determination were performed. The same tests were repeated after surgery in the cancer patients. At the same time, the immunologic modifications during chemotherapy (CMF) were studied in a further 25 premenopausal breast cancer patients. The cancer patients did not show significantly different reactivity to recall antigens, nor did surgery or chemotherapy modify this parameter. The breast cancer patients showed a significantly higher CD4+/CD8+ ratio (2.07±1.06 vs. 1.56±0.58; p",
author = "Iaffaioli, {R. V.} and G. Frasci and L. Rinaldi and {Del Vecchio}, L. and A. Tortoriello and G. Facchini and V. Perone and V. Montesarchio and C. Vacca and F. Vaia and Bianco, {A. R.}",
year = "1993",
language = "English",
volume = "14",
pages = "412--418",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "5",

}

TY - JOUR

T1 - Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients

AU - Iaffaioli, R. V.

AU - Frasci, G.

AU - Rinaldi, L.

AU - Del Vecchio, L.

AU - Tortoriello, A.

AU - Facchini, G.

AU - Perone, V.

AU - Montesarchio, V.

AU - Vacca, C.

AU - Vaia, F.

AU - Bianco, A. R.

PY - 1993

Y1 - 1993

N2 - The immunologic status of 40 breast cancer patients with operable disease and 50 healthy women was studied at the Division of Medical Oncology of the 2nd Medical School in Naples. Skin tests and lymphocyte subpopulation determination were performed. The same tests were repeated after surgery in the cancer patients. At the same time, the immunologic modifications during chemotherapy (CMF) were studied in a further 25 premenopausal breast cancer patients. The cancer patients did not show significantly different reactivity to recall antigens, nor did surgery or chemotherapy modify this parameter. The breast cancer patients showed a significantly higher CD4+/CD8+ ratio (2.07±1.06 vs. 1.56±0.58; p

AB - The immunologic status of 40 breast cancer patients with operable disease and 50 healthy women was studied at the Division of Medical Oncology of the 2nd Medical School in Naples. Skin tests and lymphocyte subpopulation determination were performed. The same tests were repeated after surgery in the cancer patients. At the same time, the immunologic modifications during chemotherapy (CMF) were studied in a further 25 premenopausal breast cancer patients. The cancer patients did not show significantly different reactivity to recall antigens, nor did surgery or chemotherapy modify this parameter. The breast cancer patients showed a significantly higher CD4+/CD8+ ratio (2.07±1.06 vs. 1.56±0.58; p

UR - http://www.scopus.com/inward/record.url?scp=0027443066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027443066&partnerID=8YFLogxK

M3 - Article

C2 - 8253104

AN - SCOPUS:0027443066

VL - 14

SP - 412

EP - 418

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 5

ER -